tiprankstipranks
TipRanksTop Financial ExpertsInsidersPaul Maier

Paul Maier Insider Profile

4 Followers
Paul Maier, Director at Eton Pharmaceuticals, holds 59.74K shares in Eton Pharmaceuticals (Ticker: ETON), holds 85.00K shares in Ambrx Biopharma (Ticker: AMAM), holds 31.71K shares in International Stem Cell (Ticker: ISCO).
See the Hottest Stocks Based on Insider Trading >
tipranks
Paul Maier

Paul Maier
Eton Pharmaceuticals (ETON)
Director

Ranked #58,652 out of 108,921 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

-3.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$28M
87.36%
12.57%
0.05%
0.02%
0.00% Others
A breakdown of Paul Maier's holdings
See the Top Stocks by Insiders

Insider Roles

Ligand Pharma
(LGND)
Sr. V-P, CFO
Eton Pharmaceuticals
(ETON)
Director
International Stem Cell
(ISCO)
Director
Pure Bioscience
(PURE)
Director
+2 other positions
Roles that Paul Maier holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
International Stem Cell
(ISCO)
Rating:Informative Sell
Date:Apr 22, 2019 - Apr 22, 2020
Return:+65.50%
The most profitable trade made by Paul Maier
See the Latest Stocks Traded by Insiders

Paul Maier's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ETON
Eton Pharmaceuticals
Aug 28, 2026
Director
Uninformative Buy
189.00K
$3.49M
AMAM
Ambrx Biopharma
Jun 09, 2023
―
Uninformative Buy
―
$2.38M
SEELQ
Seelos Therapeutics
Jan 06, 2017
Director
Uninformative Buy
―
$0.00
ISCO
International Stem Cell
Apr 22, 2019
Director
Informative Sell
1.67K
$13.32K
MBVXQ
MabVax Therapeutics Holdings
Jan 24, 2018
―
Uninformative Sell
30.30K
$539.63
AIXC
AIxCrypto Holdings
―
Director
―
$0.00
LGND
Ligand Pharma
―
Sr. V-P, CFO
―
$24.26M
SQNM
Sequenom
Feb 12, 2014
―
Uninformative Buy
―
$176.36K
PURE
Pure Bioscience
Aug 02, 2012
Director
Uninformative Buy
5.21K
$4.49K
TLON
Talon Therapeutics Inc
Jul 18, 2013
―
Uninformative Sell
―
―
List of latest transactions for each holding click on a transaction to see Paul Maier's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Paul Maier insider profile FAQ

What is the percentage of profitable transactions made by Paul Maier?
The percentage of profitable transactions made by Paul Maier is 67%.
    What is the average return per transaction made by Paul Maier?
    The average return per transaction made by Paul Maier is -3.00%.
      What stocks does Paul Maier hold?
      Paul Maier holds: ETON, AMAM, SEELQ, ISCO, MBVXQ, AIXC, LGND, SQNM, PURE, TLON stocks.
        What was Paul Maier’s latest transaction?
        Paul Maier latest transaction was an Uninformative Buy of $189.00K.
          What was Paul Maier's most profitable transaction?
          Paul Maier’s most profitable transaction was an Informative Sell of ISCO stock on April 22, 2019. The return on the trade was 65.50%.
            What is Paul Maier's role in Eton Pharmaceuticals?
            Paul Maier's role in Eton Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.